ANKTIVA 400 ug/.4mL
nogapendekin alfa inbakicept-pmln · SOLUTION · Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc.
ANKTIVA is a solution containing nogapendekin alfa inbakicept-pmln at 400 ug/.4mL, taken intravesical. Manufactured by Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc..
Key Facts
- Brand Name
- ANKTIVA
- Generic Name
- nogapendekin alfa inbakicept-pmln
- NDC Code (Product)
81481-803- Manufacturer
- Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc.
- Strength
- 400 ug/.4mL
- Dosage Form
- SOLUTION
- Route
- INTRAVESICAL
- Marketing Status
- Application #
- BLA761336
- Marketing Start
- 05/06/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is ANKTIVA used for?
ANKTIVA contains nogapendekin alfa inbakicept-pmln. It is a solution taken intravesical. Consult your doctor for specific uses.
Is ANKTIVA a controlled substance?
ANKTIVA is not classified as a controlled substance by the DEA.
What is the generic name for ANKTIVA?
The generic name for ANKTIVA is nogapendekin alfa inbakicept-pmln. There are no other listed brand versions of nogapendekin alfa inbakicept-pmln.
What is the NDC code for ANKTIVA 400 ug/.4mL?
The NDC (National Drug Code) for ANKTIVA 400 ug/.4mL is 81481-803, listed by Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)